Skip to Content

Western Sierra Resource Corp WSRC

Morningstar Rating
$0.01 0.00 (2.27%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

WSRC is trading at a 39% discount.
Price
$0.01
Fair Value
$3.83
Uncertainty
Extreme
1-Star Price
$7.39
5-Star Price
$2.73
Economic Moat
Qkwh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WSRC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.000.12
Bid/Ask
$0.01 / $0.01
Market Cap
$1.40 Mil
Volume/Avg
10,000 / 167,474

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Western Sierra Resource Corp is a multifaceted resource company and revenue producer focused on applying and expanding its $40,500,000 water rights assets. The beneficial uses of its water rights include growing industrial hemp, manufacturing, and undertaking the related eco-friendly, high-yield, project.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees

Valuation

Metric
WSRC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
WSRC
Quick Ratio
0.18
Current Ratio
0.43
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
WSRC
Return on Assets (Normalized)
−3.65%
Return on Equity (Normalized)
−4.05%
Return on Invested Capital (Normalized)
−3.96%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHrmqfvlbyXhvs$74.6 Bil
MKKGY
Merck KGaA ADRZqrcwcsvsLqwqt$70.9 Bil
HLN
Haleon PLC ADRTlsknrjjWgyc$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRXbwyftdVdrb$14.9 Bil
VTRS
Viatris IncYtkfhnvwPwnmj$13.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRZgqkqnvcYqft$12.2 Bil
CTLT
Catalent IncFgbkwwgyWmdphj$10.3 Bil
PRGO
Perrigo Co PLCCkcdgvgsPqmc$4.3 Bil
CURLF
Curaleaf Holdings IncXpytbqshXcnd$3.9 Bil
PBH
Prestige Consumer Healthcare IncMcsjflkrRmqykf$3.4 Bil

Sponsor Center